UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 12.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 703,785 shares of the healthcare conglomerate's stock after acquiring an additional 76,046 shares during the period. Victory Capital Management Inc. owned 0.08% of UnitedHealth Group worth $368,607,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Bridgewater Advisors Inc. bought a new position in UnitedHealth Group during the 1st quarter valued at about $2,425,000. Kornitzer Capital Management Inc. KS boosted its holdings in shares of UnitedHealth Group by 1.1% in the 1st quarter. Kornitzer Capital Management Inc. KS now owns 27,934 shares of the healthcare conglomerate's stock valued at $14,630,000 after buying an additional 307 shares in the last quarter. Wealthfront Advisers LLC increased its position in shares of UnitedHealth Group by 5.5% during the first quarter. Wealthfront Advisers LLC now owns 81,508 shares of the healthcare conglomerate's stock worth $42,690,000 after purchasing an additional 4,239 shares in the last quarter. GPM Growth Investors Inc. raised its stake in UnitedHealth Group by 0.4% in the 1st quarter. GPM Growth Investors Inc. now owns 7,766 shares of the healthcare conglomerate's stock worth $4,067,000 after acquiring an additional 29 shares during the last quarter. Finally, First Business Financial Services Inc. increased its stake in shares of UnitedHealth Group by 6.4% in the first quarter. First Business Financial Services Inc. now owns 4,721 shares of the healthcare conglomerate's stock worth $2,473,000 after acquiring an additional 284 shares during the period. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

UNH stock traded down $5.10 during trading on Thursday, reaching $287.39. 12,015,123 shares of the company were exchanged, compared to its average volume of 7,772,043. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a market cap of $260.70 billion, a P/E ratio of 12.03, a PEG ratio of 1.40 and a beta of 0.45. The stock's 50 day moving average price is $308.39 and its 200 day moving average price is $436.45. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the previous year, the company posted $6.91 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.08%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

Insider Activity

In related news, Director Timothy Patrick Flynn bought 1,533 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director owned 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Kristen Gil bought 3,700 shares of the firm's stock in a transaction dated Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director directly owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock worth $31,607,768 in the last quarter. Insiders own 0.28% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. Royal Bank Of Canada lowered their target price on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Robert W. Baird cut shares of UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price objective for the company. in a report on Wednesday, June 11th. HSBC reaffirmed a "reduce" rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Finally, Wells Fargo & Company reissued an "overweight" rating on shares of UnitedHealth Group in a research report on Friday, June 6th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $414.35.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.